Efficacy and safety of switching from TWIce-daily exenatide to oNce-weekly exenatide in Japanese patients with type 2 diabetes mellitus;Multicenter, Prospective, Single-arm trial
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Twin
- 02 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 26 Feb 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan record.
- 04 Feb 2015 New trial record